Concepedia

Abdolkhaegh Deezagi

AD

Statistics

Publications

3

Citations

79

H-Index

3

Active since

2013

Affiliations

National Institute of Genetic Engineering and Biotechnology(Current)

Abdolkhaegh Deezagi is an author at National Institute of Genetic Engineering and Biotechnology specializing in pharmacology, cancer pharmacology, and oncology.

Publications per year

2013–2018

3

Publications

3

A Novel Report of Apoptosis in Human Lung Carcinoma Cells Using Selective Agonist of D2-like Dopamine Receptors: A New Approach for the Treatment of Human Non-Small Cell Lung Cancer

Mojgan Sheikhpour, Ghasem Ahangari, Majid Sadeghizadeh et al. · International Journal of Immunopathology and Pharmacology · 2013 · 31 citations · Full text

, , +17

Alternative Viewpoint Against Breast Cancer Based on Selective Serotonin Receptors 5HTR3A and 5HTR2A Antagonists that can Mediate Apoptosis in MCF-7 Cell Line

Seyed Hesamaldin Hejazi, Ghasem Ahangari, Abdolkhaegh Deezagi · Current Drug Discovery Technologies · 2016 · 30 citations

, , +17

The Expression of Dopamine Receptors Gene and their Potential Role in Targeting Breast Cancer Cells with Selective Agonist and Antagonist Drugs. Could it be the Novel Insight to Therapy?

Hossein Bakhtou, Asiie Olfatbakhsh, Abdolkhaegh Deezagi et al. · Current Drug Discovery Technologies · 2018 · 18 citations

, , +16

1–3 of 3